We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Scorpius Holdings Inc (SCPX) USD0.0002

Sell:$0.10 Buy:$0.11 Change: $0.0006 (0.58%)
Market closed |  Prices as at close on 12 June 2024 | Switch to live prices |
Sell:$0.10
Buy:$0.11
Change: $0.0006 (0.58%)
Market closed |  Prices as at close on 12 June 2024 | Switch to live prices |
Sell:$0.10
Buy:$0.11
Change: $0.0006 (0.58%)
Market closed |  Prices as at close on 12 June 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Scorpius Holdings, Inc., formerly NightHawk Biosciences, Inc., is an integrated contract development and manufacturing company. The Company is focused on advancing biologic and cell therapy programs to the clinic and beyond. It offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio, Texas. Its analytical services include development of a comprehensive range of analytical test methods to characterize complex biologics, including cell therapy-based products, protein therapeutics, vaccines and advanced therapies. Its Clinical Biomanufacturing includes cGMP Mammalian Cell Culture, and cGMP Microbial Fermentation. Its San Antonio facility is focused on the commercial-scale manufacturing of biodefense-focused molecules and biologics therapeutics. Its biomanufacturing services focus on accelerating product development timelines from pre-clinical evaluation to first-in-human studies.

Contact details

Address:
627 DAVIS DRIVE, SUITE 300
MORRISVILLE
27560
United States
Telephone:
+1 (919) 2407133
Website:
https://www.nighthawkbio.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
SCPX
ISIN:
US42237K4094
Market cap:
$10.27 million
Shares in issue:
96.66 million
Sector:
Biotechnology
Exchange:
-
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Jeffrey Wolf
    Chairman of the Board, President, Chief Executive Officer
  • William Ostrander
    Chief Financial Officer, Controller, Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.